NURIX THERAPEUTICS, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2020-03-26: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-03-09; Total offering amount $120,249,972.
- 2015-09-18: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-09-03; Total offering amount $17,033,334.
- 2014-01-02: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2013-12-18; Total offering amount $25,150,000.
- 2013-03-28: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2012-04-30; Total offering amount $5,300,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2020-03-26 | Rule 506(b) | Equity | 2020-03-09 | $120,249,972 | $120,249,972 | $0 | 23 |
| 2015-09-18 | Rule 506(b) | Equity | 2015-09-03 | $17,033,334 | $17,033,334 | $0 | 1 |
| 2014-01-02 | Rule 506(b) | Equity | 2013-12-18 | $25,150,000 | $2,075,000 | $23,075,000 | 2 |
| 2013-03-28 D/A | Rule 506 | Equity | 2012-04-30 | $5,300,000 | $5,300,000 | $0 | 4 |
| 2012-05-16 | Rule 506 | Equity | 2012-04-07 | $1,800 | $1,800 | $0 | 1 |
| 2012-05-15 | Rule 506 | Equity | 2012-04-30 | $3,100,000 | $3,100,000 | $0 | 4 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |